Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

c-Rel is a cell cycle modulator in human melanoma cells.

Priebe MK, Dewert N, Amschler K, Erpenbeck L, Heinzerling L, Schön MP, Seitz CS, Lorenz VN.

Exp Dermatol. 2018 Nov 22. doi: 10.1111/exd.13848. [Epub ahead of print]

PMID:
30466153
2.

Morphological Plasticity of Human Melanoma Cells is Determined by Nanoscopic Patterns of E- and N-Cadherin Interactions.

Amschler K, Beyazpinar I, Erpenbeck L, Kruss S, Spatz JP, Schön MP.

J Invest Dermatol. 2018 Oct 27. pii: S0022-202X(18)32710-6. doi: 10.1016/j.jid.2018.09.027. [Epub ahead of print]

PMID:
30393081
3.

Chromatin swelling drives neutrophil extracellular trap release.

Neubert E, Meyer D, Rocca F, Günay G, Kwaczala-Tessmann A, Grandke J, Senger-Sander S, Geisler C, Egner A, Schön MP, Erpenbeck L, Kruss S.

Nat Commun. 2018 Sep 14;9(1):3767. doi: 10.1038/s41467-018-06263-5.

4.

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.

Schön MP, Erpenbeck L.

Front Immunol. 2018 Jun 15;9:1323. doi: 10.3389/fimmu.2018.01323. eCollection 2018. Review.

5.

Control of Integrin Affinity by Confining RGD Peptides on Fluorescent Carbon Nanotubes.

Polo E, Nitka TT, Neubert E, Erpenbeck L, Vuković L, Kruss S.

ACS Appl Mater Interfaces. 2018 May 30;10(21):17693-17703. doi: 10.1021/acsami.8b04373. Epub 2018 May 15.

PMID:
29708725
6.

Nanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.

Amschler K, Kossmann E, Erpenbeck L, Kruss S, Schill T, Schön M, Möckel SMC, Spatz JP, Schön MP.

Mol Cancer Res. 2018 Mar;16(3):528-542. doi: 10.1158/1541-7786.MCR-17-0272. Epub 2017 Dec 8.

7.

Wege zum Verständnis neutrophiler Dermatosen.

Schön MP, Erpenbeck L.

J Dtsch Dermatol Ges. 2017 Nov;15(11):1075-1076. doi: 10.1111/ddg.13367. No abstract available.

PMID:
29106023
8.

Peptidylarginine deiminase 4 promotes age-related organ fibrosis.

Martinod K, Witsch T, Erpenbeck L, Savchenko A, Hayashi H, Cherpokova D, Gallant M, Mauler M, Cifuni SM, Wagner DD.

J Exp Med. 2017 Feb;214(2):439-458. doi: 10.1084/jem.20160530. Epub 2016 Dec 28.

9.

PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model.

Erpenbeck L, Chowdhury CS, Zsengellér ZK, Gallant M, Burke SD, Cifuni S, Hahn S, Wagner DD, Karumanchi SA.

Biol Reprod. 2016 Dec;95(6):132. doi: 10.1095/biolreprod.116.140293. Epub 2016 Nov 9.

10.

Neutrophil extracellular traps: protagonists of cancer progression?

Erpenbeck L, Schön MP.

Oncogene. 2017 May 4;36(18):2483-2490. doi: 10.1038/onc.2016.406. Epub 2016 Dec 12. Review.

PMID:
27941879
11.

Sexy again: the renaissance of neutrophils in psoriasis.

Schön MP, Broekaert SM, Erpenbeck L.

Exp Dermatol. 2017 Apr;26(4):305-311. doi: 10.1111/exd.13067. Epub 2017 Feb 27.

PMID:
27194625
12.

ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.

Erpenbeck L, Demers M, Zsengellér ZK, Gallant M, Cifuni SM, Stillman IE, Karumanchi SA, Wagner DD.

J Am Soc Nephrol. 2016 Jan;27(1):120-31. doi: 10.1681/ASN.2014121165. Epub 2015 Jun 2.

13.

Nanoscale integrin ligand patterns determine melanoma cell behavior.

Amschler K, Erpenbeck L, Kruss S, Schön MP.

ACS Nano. 2014 Sep 23;8(9):9113-25. doi: 10.1021/nn502690b. Epub 2014 Sep 3.

PMID:
25171587
14.

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.

Quack H, Erpenbeck L, Wolff HA, Sprenger T, Seitz CS, Schön MP, Neumann S, Stanek K, Ghadimi BM, Michels B, Middel P, Schaefer IM, Liersch T, Conradi LC.

Case Rep Oncol. 2013 Dec 11;6(3):609-15. doi: 10.1159/000357166. eCollection 2013 Sep.

15.

VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice.

Savchenko AS, Borissoff JI, Martinod K, De Meyer SF, Gallant M, Erpenbeck L, Brill A, Wang Y, Wagner DD.

Blood. 2014 Jan 2;123(1):141-8. doi: 10.1182/blood-2013-07-514992. Epub 2013 Nov 7.

16.

Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα.

Kruss S, Erpenbeck L, Amschler K, Mundinger TA, Boehm H, Helms HJ, Friede T, Andrews RK, Schön MP, Spatz JP.

ACS Nano. 2013 Nov 26;7(11):9984-96. doi: 10.1021/nn403923h. Epub 2013 Oct 4.

17.

Circular, nanostructured and biofunctionalized hydrogel microchannels for dynamic cell adhesion studies.

Kruss S, Erpenbeck L, Schön MP, Spatz JP.

Lab Chip. 2012 Sep 21;12(18):3285-9. doi: 10.1039/c2lc40611j. Epub 2012 Aug 2.

18.

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.

Erpenbeck L, Schön MP.

Blood. 2010 Apr 29;115(17):3427-36. doi: 10.1182/blood-2009-10-247296. Epub 2010 Mar 1. Review.

19.

Constitutive and functionally relevant expression of JAM-C on platelets.

Erpenbeck L, Rubant S, Hardt K, Santoso S, Boehncke WH, Schön MP, Ludwig RJ.

Thromb Haemost. 2010 Apr;103(4):857-9. doi: 10.1160/TH09-08-0572. Epub 2010 Feb 2. No abstract available.

PMID:
20135068
20.

NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.

Amschler K, Schön MP, Pletz N, Wallbrecht K, Erpenbeck L, Schön M.

J Invest Dermatol. 2010 Apr;130(4):1073-86. doi: 10.1038/jid.2009.365. Epub 2009 Nov 26.

Supplemental Content

Loading ...
Support Center